Goldman Sachs Group Inc.'s heavy reliance on trading and investment banking drove up revenue by 41 percent to $13.30 billion while avoiding losses due to the coronavirus in the second quarter.
Goldman's second-quarter earnings of 2.2 billion, or $6.26 per share, exceeded analysts' expectations of earning $3.78 per share.
Its quarterly profit jumped 2 percent year-over-year.
While investors celebrated Goldman's ability to trade through the crisis, it remains to be seen whether it can sustain performance in subsequent quarters with other expecting trading revenue to fall in the coming months.
Chief Executive David Solomon acknowledged that his plan to boost its wealth-management division has become difficult due to financial advisors' inability to meet new clients during the pandemic personally.
Unlike rivals JPMorgan Chase & Co and Citigroup Inc, Goldman's fledgling presence in consumer banking resulted in much fewer credit losses.
However, Goldman had to deal with other problems, including adding to regulatory capital and setting aside $945 million for potential legal and regulatory costs.
Goldman has been in talks regarding its involvement in the Malaysian sovereign wealth fund 1MDB corruption scandal.
The company also set aside $1.6 billion for loans that could go bad, most of which were unrelated to its consumer business.
Goldman's 11.1 percent return-on-equity in the second quarter would have been over 15 percent if it had not set aside money for capital goals and legal reserves.


Google to Move All Pixel Production Out of China by 2027
Samsung Eyes $72 Billion Shareholder Return Plan as AI Chip Boom Fuels Profits
Coty Revenue Beats Estimates as Beauty Demand Holds Firm
Shein Targets $26B-$27B Valuation for Hong Kong IPO
Moody’s Affirms NVIDIA Aa1 Rating as AI Data Center Guarantees Reach $105 Billion
SEC Sues Former Tricolor Executives Over $1.9 Billion Investor Fraud Scheme
Schott Pharma Stock Rises as Barclays Upgrades Rating on Growth Outlook
Alibaba Sells Lingxi Games for Over $1.5 Billion Amid AI Push
Nordson Stock Rises as Q3 Earnings Beat Estimates, Outlook Raised
AstraZeneca Halts Phase III Volrustomig Lung Cancer Trial After Efficacy Setback
Baidu Shares Sink to One-Year Low as Ad Weakness Overshadows AI Growth
SK Hynix Shares Surge on Record $28.6 Billion Buyback
OpenAI Tightens AI Safety Monitoring After Security Incidents
Toyota, Honda Shares Rise on Possible U.S.-Canada Auto Tariff Cut
BofA Sees Micron EPS Topping $230 by 2030, Backs Major Stock Upside
Standard Chartered Expands Hedge Fund Access for Wealth Clients
Sun Pharma Wins U.S. Appeal in Pfizer Lipitor Antitrust Case 



